Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Ionis Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

05 Feb 2016 Reuters Investment Profile 12 $20.00

Trading Report for (ISIS). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for ISIS. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

08 Feb 2016 Stock Traders Daily 6 $20.00

IONS: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

08 Feb 2016 New Constructs, LLC 10 $25.00

ValuEngine Rating and Forecast Report for IONS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

07 Feb 2016 ValuEngine, Inc. 11 $25.00

Thomson Reuters Stock Report - Ionis Pharmaceuticals Inc (IONS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 12 $25.00


05 Feb 2016 Ford Investor Services, Inc. 1 $12.00

Wright Investors Service Comprehensive Report for Ionis Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

22 Jan 2016 Wright Reports 56 $75.00

IONS.OQ - Event Transcript of Ionis Pharmaceuticals Inc conference call, Jan. 11, 2016 / 5:30PM ET

Edited Event Transcript of IONS.OQ conference call, Jan. 11, 2016 / 5:30PM ET San Francisco, Jan 12, 2016 (Thomson Stre...

11 Jan 2016 Thomson Reuters StreetEvents 6 $75.00

Ionis Pharmaceuticals

09 Jan 2016 S&P Capital IQ Quantitative Report 9 $104.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ISIS PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

31 Dec 2015 Jefferson Research 11 $20.00